Evonik Evonik

X

Find the latest Drugs in Development and Pipeline Prospector News of Edenbridge Pharmaceuticals.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Edenbridge Pharmaceuticals
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
169 Lackawanna Avenue, Suite 110 Parsippany, NJ 07054
Telephone
Telephone
201-292-1292
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

Both companies signed a commercial supply agreement, for a novel formulation of glycopyrrolate (Dartisla) using Catalent’s proprietary Zydis® orally disintegrating tablet delivery technology intended for use as adjunctive therapy in the treatment of patients with peptic ulcer.


Lead Product(s): Glycopyrronium Bromide

Therapeutic Area: Gastroenterology Product Name: Dartisla

Highest Development Status: Phase IIIProduct Type: Small molecule

Recipient: Catalent Pharma Solutions

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement August 10, 2021

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY